China Pharma Holdings (CPHI) EPS (Weighted Average and Diluted): 2009-2025
Historic EPS (Weighted Average and Diluted) for China Pharma Holdings (CPHI) over the last 10 years, with Sep 2025 value amounting to -$0.17.
- China Pharma Holdings' EPS (Weighted Average and Diluted) rose 73.85% to -$0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.41, marking a year-over-year increase of 161.84%. This contributed to the annual value of -$0.27 for FY2024, which is 70.33% up from last year.
- According to the latest figures from Q3 2025, China Pharma Holdings' EPS (Weighted Average and Diluted) is -$0.17, which was down 6.25% from -$0.16 recorded in Q2 2025.
- Over the past 5 years, China Pharma Holdings' EPS (Weighted Average and Diluted) peaked at $1.98 during Q4 2024, and registered a low of -$0.89 during Q2 2024.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.13, with a median of -$0.24 in 2025.
- Examining YoY changes over the last 5 years, China Pharma Holdings' EPS (Weighted Average and Diluted) showed a top increase of 10,000.00% in 2024 and a maximum decrease of 124.14% in 2024.
- China Pharma Holdings' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.02 in 2023, then skyrocketed by 10,000.00% to $1.98 in 2024, then surged by 73.85% to -$0.17 in 2025.
- Its last three reported values are -$0.17 in Q3 2025, -$0.16 for Q2 2025, and -$0.24 during Q1 2025.